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Bacterial infections still constitute a major cause of mortality and morbidity worldwide. The 27 
unavailability of therapeutics, antimicrobial resistance and the chronicity of infections due to 28 
incomplete clearance contribute to this phenomenon. Despite the progress in antimicrobial and 29 
vaccine development, knowledge about the effect that therapeutics have on the host-bacteria 30 
interactions remains incomplete. Insights into the characteristics of bacterial colonisation and 31 
migration between tissues, and the relationship between replication and host- or 32 
therapeutically-induced killing can enable efficient design of treatment approaches. Recently, 33 
innovative experimental techniques have generated data enabling the qualitative 34 
characterisation of aspects of bacterial dynamics. Here, we argue that mathematical modelling 35 
as an adjunct to experimental data can enrich the biological insight that these data provide. 36 
However, due to limited interdisciplinary training, efforts to combine the two remain limited. 37 
To promote this dialogue, we provide a categorisation of modelling approaches highlighting 38 
their relationship to data generated by a range of experimental techniques in the area of in vivo 39 
bacterial dynamics. We outline common biological themes explored using mathematical 40 
models with case studies across all pathogen classes. Finally, this review advocates 41 
multidisciplinary integration to improve our mechanistic understanding of bacterial infections 42 
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1.  Introduction 50 
 51 
Bacterial infections have historically been classified amongst the leading causes of death in 52 
humans (World Health Organisation, 2019). The discovery and clinical introduction of 53 
antibiotics during the 20th century significantly reduced the morbidity and mortality of 54 
bacterial diseases (Yoshikawa, 2002). However, the rise of resistance to most first-line 55 
antibiotics (reviewed by Hofer, 2018) and antibiotic tolerance (reviewed by Brauner et al., 56 
2016) compounded by inequities in antimicrobial access (Center for Disease Dynamics, 57 
Economics & Policy, 2019) persistently undermine efforts to lower the burden of bacterial 58 
diseases.  59 
 60 
In light of these challenges, immunisation of vulnerable populations (Breiman et al., 2012) and 61 
pathogen-specific optimisation of antibiotic regimens (Meylan, Andrews and Collins, 2018) 62 
have emerged as promising management strategies. However, neither novel antibiotic agents 63 
(Silver, 2011) nor new vaccines are being developed fast enough (Pronker et al., 2013) to keep 64 
bacterial diseases in check. Even for most vaccines currently in use the mode of action at the 65 
level of host-pathogen interactions remains obscure (Oyston and Robinson, 2012), while lack 66 
of an integrated understanding of the dysfunctional host-pathogen interactions targeted by 67 
antimicrobial agents leads to the underutilisation of their therapeutic potential (Munguia and 68 
Nizet, 2017). Concomitant with efforts to boost the rates of discovery of novel therapeutics, it 69 
is imperative to optimise the use of already available agents by disentangling the complex 70 
interactions between host immunity and pathogen behaviour (Gjini and Brito, 2016), and 71 
identifying the determinants of successful disease establishment and progression (Munguia and 72 
Nizet, 2017; Casadevall and Pirofski, 2001).  73 
 74 
From first principles, therapeutic interventions should aim to reduce or eliminate the 75 
pathogenic bacteria from the infected host. This outcome can be achieved by slowing down 76 
bacterial replication, accelerating bacterial killing, altering bacterial migration between tissues 77 
or any favourable combination thereof. Although bacterial growth and dissemination have been 78 
extensively studied in terms of molecular and cellular mechanisms (reviewed by Endesfelder, 79 
2019; Ribet and Cossat, 2015), the efforts to quantify these processes and their change in 80 
response to therapeutic interventions remain limited (Levin and Antia, 2001). Quantification 81 
of these dynamics requires a detailed observation of within-host bacterial behaviour by means 82 
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of suitable experimental studies and high-resolution imaging and tracking technologies. 83 
However, despite the rapidly evolving technological advancements that have improved the 84 
resolution of experimental observations, many biological phenomena of interest still remain 85 
directly unobservable. This observational gap can be partly filled through quantitative 86 
inferences about the missing information with the use of mathematical models applied to 87 
relatively coarse experimental data. 88 
 89 
In this review, we categorise mathematical models according to their appropriateness for 90 
capturing different characteristics of infection progression, and their degree of dependence on 91 
experimental data. We focus on mechanistic, data-driven models and explain their contribution 92 
to applied microbiological research. We outline commonly used experimental techniques in 93 
the study of within-host bacterial dynamics and discuss ways in which their output has been or 94 
can be enriched by suitable mathematical approaches. Finally, we broaden our scope to models 95 
applied to viral and parasitic infections to showcase a number of biological themes that have 96 
been successfully addressed using such modelling techniques. 97 
  98 
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2.  Experimental and Mathematical Models as Representations of Biological 99 
Systems  100 
 101 
In a biological context, a model is defined as a simplified representation of a system or 102 
phenomenon summarising knowledge of that system in a usable form (Eykhoff, 1974). While 103 
experimental models are physical representations of the real-life system either in vivo or in 104 
vitro, mathematical models are conceptual and usually formulated as systems of mathematical 105 
equations processed either analytically or numerically (Motta and Pappalardo, 2013). 106 
 107 
Though microbiologists are familiar with experimental models, they are less so with the 108 
versatility of mathematical modelling approaches, largely due to the limited interdisciplinary 109 
training in biological sciences (Levin and Antia, 2001). In this section, we aim to provide a 110 
convenient introduction to mathematical models by classifying modelling techniques 111 
according to their comparative strengths and applications to microbiological questions. 112 
 113 
Mathematical models can be categorised into functional classes (Figure 1), according to 114 
different criteria such as (1) whether their parameters represent biological processes, (2) 115 
whether they are fitted to experimental data, (3) whether molecular, cellular or other sources 116 
of variability affect the output of the model, (4) what the purpose of model development is. 117 
 118 
 119 
2.1. Mechanistic and Empirical Models 120 
 121 
Mathematical models can be classified as empirical or mechanistic. Empirical models 122 
describe relations between the variables in an experimental dataset, without addressing what 123 
biological mechanisms may intrinsically drive the observed patterns in the data. These relations 124 
can be quantified by parameters, whose values can be estimated using statistical analysis. 125 
Empirical models are also known as extrinsic because they do not incorporate any knowledge 126 
or hypotheses about the inner structural connectivity of the system; rather they are only based 127 





















Figure 1: Schematic representation of the relationships between different mathematical 147 
modelling techniques. 148 
 149 
Mathematical models can be divided into mechanistic and empirical on account of whether their 150 
parameters represent biological processes or simply characterise relations between variables in the 151 
data.  While empirical models are necessarily data-dependent, mechanistic models can either be 152 
system-specific and fitted to data or, generic, explorative and not related to experimental data 153 
(theoretical). Additionally, depending on the biological question addressed, mechanistic models can be 154 
deterministic when only the average behaviour of the system is of interest, or stochastic when 155 
unexplained variation in the behaviour of the system matters too. Mechanistic data-driven models can 156 
serve different purposes: they can either be solved forward in time to make a forecast (prospective 157 
analysis) or can be solved backwards in time to perform parameter inference and model selection 158 
(retrospective analysis). 159 
 160 
By contrast, mechanistic models incorporate the biological mechanisms by which changes in 161 
the system are thought to occur and require some knowledge or speculation about the 162 
unobserved interactions that determine the observable output (Baker et al., 2018; Thakur, 163 
1991).  In the context of mathematical modelling, a mechanism often does not correspond to 164 
the molecular, cellular or genetic hierarchy that collectively constitutes causality from a 165 
microbiologist’s viewpoint. From a modeller’s point of view, a mechanism is a conceptual 166 
EMPIRICAL 
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3. Does the model 





representation of the process acting to change the state of the system in a certain 167 
direction.  Structurally, mechanistic models can be represented with flow diagrams, whereby 168 
the state of the biological system, i.e. an imaginary complete snapshot of that system at a given 169 
point in time, changes through processes measured by parameters in the model (Figure 2). 170 
Examples of biologically relevant quantities encoded as variables in these models (i.e. boxes 171 
in the flow diagram) can include concentrations of cytokines and antibodies, as well as numbers 172 
of immune cells and infectious agents in tissues amongst others. These quantities are at times 173 
directly measurable experimentally and at others only determinable by proxy. 174 
 175 
 176 
Figure 2: An example of a flow diagram as a schematic 177 
representation of mechanistic models in microbiology 178 
(adapted from Kaiser et al., 2013) 179 
 180 
Boxes represent the variables of the system, in this case the 181 
number of bacteria in the caecum and caecal lymph node 182 
respectively. Mathematically these variables are shortened 183 
for convenience as NC and NL. The processes that change 184 
the state of the system are represented by arrows and, here, 185 
correspond to bacterial migration, replication and clearance. 186 
The rates at which these processes take place are quantified 187 
by parameters, in this case, μL, rL, cL corresponding to the 188 





2.2. Data-driven and Theoretical Models 194 
 195 
The second relevant classification of mathematical models is that into data-driven and 196 
theoretical. While empirical models are, by definition, data-driven, mechanistic models can 197 
be of either class. Mechanistic data-driven models are usually system-specific and 198 
parameterised based on experimental outputs. For example, in 2014, Coward et al. carried out 199 
an experiment using individually-tagged strains of Salmonella Typhimurium to determine the 200 
effects of different vaccines on the rates of replication and killing of bacteria. The 201 
measurements of bacterial numbers in the differentially-tagged subpopulations along the 202 
infection timeline were fed into a population-based mathematical model, which permitted 203 
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estimation of the rates of replication and killing of bacteria under the two immunisation 204 
regimens enabling the direct comparison between them. 205 
 206 
On the other hand, theoretical models constitute a spectrum depending on the degree to which 207 
their parameterisation is empirically informed. At one end of this spectrum, there are purely 208 
theoretical models, which may describe a general pattern of infection without reference to a 209 
particular host-pathogen interaction. For example, Antia, Levin and May (1994) developed a 210 
general, theoretical model to investigate the relationship between the host’s immune system 211 
and the virulence of a generic microparasite. They found that pathogens with intermediate 212 
replication rates tend to dominate their host and achieve the highest inter-host transmissibility.  213 
 214 
Further along the spectrum, there are theoretical models referring to a specific host-pathogen 215 
system, but arbitrarily parameterised with biologically plausible values. Cooper and Julius 216 
(2011) explored a theoretical model of bacterial persistence with short- and long-term 217 
dormancy and used a simulation-based approach, whereby some parameters were allowed to 218 
vary across a biologically plausible range, to conclude that the infinite-time-horizon optimal 219 
treatment strategy is not unique.  220 
 221 
Finally, at the other end of the spectrum, there are empirically-informed theoretical models 222 
which use parameter values from a range of studies, with the potential caveat that their variable 223 
experimental sources, initial conditions or even host species may be incongruent. This 224 
limitation is counterbalanced by the benefit of maximising information through data integration 225 
across studies and scales.  For example, a substantial body of modelling work on the within-226 
host dynamics of Mycobacterium tuberculosis has used diverse experimental datasets focusing 227 
on different aspects of the immune response elicited in the lungs of human, murine and simian 228 
hosts (reviewed by Kirschner et al., 2017). Such models have attempted to integrate data at 229 
different scales (from molecular, cellular to organ- and organism-level) and simulate the 230 
response to different vaccines and antibiotic regimes. Pienaar et al. (2015, 2016) used a 231 
theoretical model partly calibrated on data derived from non-human primates and rabbits to 232 
predict the efficacy of rifampin and isoniazid combination treatment regimens, and to show 233 
that bacteria residing within macrophages constitute a reservoir for the development of 234 




2.3. Deterministic and Stochastic Models 237 
 238 
Mechanistic models can be further subdivided into deterministic and stochastic. 239 
Deterministic models follow a predetermined trajectory given a set of starting conditions and 240 
rates at which processes evolve in time. That is, a given parameter set will always yield the 241 
same model output. By contrast, stochastic models yield different results each time when 242 
initialised with the same parameters and initial conditions. While multiple realisations of 243 
stochastic models recapitulate the range of potential outcomes and their likelihood of 244 
occurrence, the output of a deterministic model corresponds to the mean outcome of these 245 
realisations. Stochastic models can quickly become too complex to solve analytically, and their 246 
exploration may, thus, be entirely simulation-based. When stochastic processes are simulated, 247 
the random nature of trajectories generated are due to randomly, exponentially distributed, 248 
picked times until the next process, with a randomly picked process executed during that time 249 
(Gillespie, 1977). This can become computationally expensive.  250 
 251 
Despite the higher computational cost of stochastic models, they often constitute the only 252 
reasonable modelling choice, when the behaviour of the system in question is particularly 253 
influenced by stochasticity. With terminology borrowed from the field of ecology, the 254 
uncertainty in the outcome can be decomposed as a function of two sources of stochasticity: 255 
demographic (e.g. Shaffer, 1981; Burgman et al., 1993) and environmental (Braumann, 2010). 256 
Demographic events include births, deaths and migration of individuals. The rate at which a 257 
demographic event occurs is defined as the inverse of the average time it takes for the event to 258 
take place and can be quantified with mathematical models. These events are described by 259 
binary random variables with a certain probability of occurring per given unit of time. As 260 
demographic events at the population-level are a function of the sum of demographic events at 261 
the individual level, the strength of demographic stochasticity is greater for small populations 262 
(Kokko and Ebenhard, 1996).  263 
 264 
On the other hand, environmental stochasticity is independent of the individual; rather, it refers 265 
to unpredictable changes in the environmental conditions that the individuals experience. As 266 
such, its effects do not depend on the population size, but on the number, heterogeneity and 267 
stability of factors influencing individual behaviour (Fujiwara and Takada, 2017).  In the 268 
context of within-host infectious dynamics, the nature of the pathogen determines the strength 269 
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of each source of stochasticity. For infections requiring a small founding population, 270 
demographic stochasticity becomes important as they may either be successful or become 271 
extinct. At the same time, the complexity of the immune response, the microenvironment of 272 
the tissue(s) colonised, and the heterogeneity of infectious foci determines the effect of 273 
environmental stochasticity on the population. When prior biological knowledge indicates that 274 
either source of stochasticity may be strong, it is advisable to use stochastic rather than 275 
deterministic models.  276 
 277 
HIV is a good case in point to illustrate how considerable these effects can be. The first models 278 
of within-host HIV dynamics were deterministic (Nowak and Bangham, 1996), but failed to 279 
account for extinction events. Later biological insights about the low probability of HIV 280 
transmission per coital act gave rise to the hypothesis that upon low level viral transmission, 281 
extinction of the infection may be more probable than take-off. Stochastic HIV models were 282 
then introduced to test this hypothesis (Pearson, Krapivsky and Perelson, 2011) and have now 283 
been established as an important tool in HIV modelling literature. 284 
 285 
 286 
2.4. Prospective and Retrospective Analysis  287 
 288 
Mathematical models can be used for prospective or retrospective analysis, according to their 289 
intended purpose in a study. Models can have a forward solution, when the initial conditions 290 
and parameters are known or chosen a priori by the modeller. They can predict what the state 291 
of the system will be at different timepoints in the future under different conditions. One 292 
common application of prospective modelling is the comparison of the effect of therapeutic 293 
interventions on infectious load reduction (e.g. Pienaar et al., 2015, Grant et al., 2008).  294 
 295 
A model can also be solved backwards when the parameters are unknown but the outputs at 296 
different timepoints are known. When analysed retrospectively, mechanistic models can be 297 
used to infer the unknown parameters. The inference process explores the parameter space, 298 
which consists of all allowed parameter combinations. For each parameter combination, the 299 
model is used to predict the state of the system at time points on interest. The state of the system, 300 
as predicted by the model given a set of parameters, is then compared to the experimental 301 
observations using statistical tools. The parameter set whose corresponding predicted output is 302 
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the closest to the experimentally observed data is taken as the best parameter estimate resulting 303 
from the inference process. An example of a mechanistic model analysed retrospectively with 304 
the purpose of parameter inference is provided by Dybowski et al. (2015). They infected mice 305 
with a mixture of isogenically-tagged bacteria derived either from liquid culture or recovered 306 
from previously infected mice. They fitted a mechanistic model to experimental measurements 307 
of numbers of bacteria per tagged strain to infer the unobserved replication and killing rates of 308 
bacteria and concluded that in vivo passage of bacteria affects their within-host dynamics in 309 
subsequent infections. 310 
 311 
Mechanistic models, analysed retrospectively, can also be used in the context of model 312 
selection to address competing hypotheses about a biological process, and these hypotheses 313 
can be tested by fitting the models to experimental data. Models with poor fit are unlikely to 314 
represent plausible candidates for the underlying biological mechanism. For instance, Handel, 315 
Longini, and Antia (2010) tested different hypotheses about the immune response to influenza 316 
A. Using model selection, they rejected the hypothesis that regrowth of epithelial cells affects 317 
the rate at which the infection progresses and highlighted the need for additional experimental 318 
data to test more detailed hypotheses about this immune response.  319 
 320 
It is important to note that the prospective and retrospective features of models are not mutually 321 
exclusive. A model can be used retrospectively and prospectively for both parameter inference 322 
and forecast, respectively. Parameters can be inferred by solving the model backwards using a 323 
fraction of the observed measurements. Then, the model, parameterised with the estimated 324 
values, can be used to predict future outcomes (forward solution). If the predicted outcomes 325 
match the remaining experimental observations, the model can be validated (Steyerberg and 326 
Harrel Jr, 2016). 327 
 328 
  329 
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3. Mathematical Models Integrated with Experimental Techniques 330 
  331 
Previously, we used examples to illustrate how different forms of mathematical modelling can 332 
be used to understand different aspects of host-pathogen interactions. The added value that a 333 
data-based mathematical model brings depends on multiple factors, including the 334 
understanding of the biological processes driving the system, the fidelity with which the 335 
putative biological knowledge has been translated to a mathematical model, and the quality 336 
and resolution of the experimental data used in model calibration. While the former two factors 337 
depend on the knowledge about the biological system of interest, the latter depends on the 338 
availability of relevant technology and know-how, and on a good understanding of the format 339 
and quality of experimental output required by the model.  340 
 341 
This section briefly reviews experimental techniques commonly used to observe bacterial 342 
growth in vivo and outlines the scope for their use with mathematical models. Table 1 343 
summarises the studies that have hitherto attempted to characterise processes that shape the 344 
within-host bacterial dynamics, highlighting the nature of the experimental technique used, 345 
whether the setup characterised the process at the level of the single bacterium or the entire 346 
population, and whether an average or a distribution of the unit (e.g. rate or elapsed generations) 347 
was obtained. This structured framework of pairwise technique-model combinations aspires to 348 
serve as a preliminary template for lab-based microbiologists to consider ways in which their 349 

























































S. enterica *  Hormaeche et al., 1980 
S. enterica * Maw and Meynell, 
1968 
E. coli *                     Meynell, 1959 
S. enterica * Gulig and Doyle, 1993 
H. influenzae* Moxon and Murphy, 
1978 
L. monocytogenes* Bakardjiev et al., 2006 
S. aureus* McVicker et al., 2014 
     E. coli** Fenoy and Bonhoeffer, 
2018 














































S. enterica* Grant et al., 2008 
qPCR L. monocytogenes* Melton-Witt et al., 
2011 
    
qPCR E.coli* Schwartz et al., 2011     
qPCR E. coli* Walters et al., 2012 
qPCR S. enterica* Kaiser et al., 2013 
qPCR B. anthracis* Lowe et al., 2013 
qPCR S. enterica* Coward et al., 2014 
Sequencing S. pneumoniae* Gerlini et al., 2014 
qPCR S. enterica* Kaiser et al., 2014 
qPCR, 
Sequencing 
S. enterica* Lim et al., 2014 
qPCR S. enterica* Lam and Monack, 2014 
qPCR S. enterica* Maier et al., 2014 
PCR B. burgdorferi* Rego et al., 2014 
Sequencing V. cholerae* Abel et al., 2015 
qPCR S. enterica* Dybowski et al., 2015 
SB Y. pestis* Gonzalez et al., 2015 
Sequencing S. enterica* Rossi et al., 2017 
Sequencing L. monocytogenes* Zhang et al., 2017 
Sequencing M. tuberculosis* Martin et al., 2017 
   
 
      













S. enterica* Helaine et al., 2010 
FACS S. enterica* Claudi et al., 2014 
FC S. enterica* Helaine et al., 2014 
FC Population Average E.coli*** Myhrvold et al., 2015 
      









FM   S. enterica* Sheppard et al., 2003 
FM S. enterica* Brown et al., 2006 
CLSM E. coli* Schwartz et al., 2011 
LI B. anthracis** Plaut et al., 2012 
LI S. aureus* Prajsnar et al., 2012 
 FM   V. cholerae* Millet et al., 2014 
Peak-to-trough ratio Sequencing Replication Population Average Mixed bacteria* Korem et al., 2016 
Table 1:  Summary of studies characterising processes shaping bacterial dynamics 
(*) Ex vivo  (**) In vivo   (***) In vitro 
FACS = Fluorescence Activated Cell Sorting  LI = Live Imaging       
FM = Fluorescence Microscopy   FC = Flow Cytometry 
SB = Southern Dot Blot Analysis   CLSM = Confocal Laser Scanning Microscopy 
qPCR = quantitative Polymerase Chain Reaction 
 
Data analysed using mechanistic mathematical models 
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3.1. Marker-based methods 368 
The first marker-based methods used to measure the population-averaged rate of bacterial 369 
replication in vivo were additive, in the sense that they involved an accessory genetic element, 370 
including superinfecting bacteriophages (Hormaeche et al., 1980; Maw and Meynell, 1968; 371 
Meynell, 1959), temperature-sensitive plasmids (Gulig and Doyle, 1993) or plasmids carrying 372 
antimicrobial resistance genes (Moxon and Murphy, 1978). In these techniques, genetic 373 
elements that induce phenotypic changes are introduced into bacteria and upon division 374 
segregate to daughter cells, leading to a reduction in the concentration of the marker, as the 375 
bacteria divide.  The growth of the bacterial population can be modelled with the generation 376 
time of the population, signifying the half-life of the marker. At each bacterial generation, we 377 
would expect to find one-half less of the bacteria in the population harbouring the non-genetic 378 
marker. 379 
Additive marker-based methods have fallen out of favour for higher-resolution experimental 380 
techniques, as their output, which is based on detection of phenotypic differences, limits the 381 
potential for mathematical inference. Because the concentration of the marker decays with each 382 
subsequent bacterial division, the technique is limited to a finite number of generations and is 383 
only appropriate for studying the early stages of infection. Additionally, the possible detectable 384 
phenotypes constitute a limiting factor for the resolution of this technique.  385 
To overcome these limitations, non-phenotypic marker-based techniques based on modifying 386 
the bacterial genome were developed, offering the added advantages of unrestricted 387 
observational potential in time, tracking of inter-organ bacterial migration, and increased 388 
resolution thanks to a broader range of possible unique markers. In contrast to their 389 
predecessors, they introduce modifications to the core bacterial genome, in the form of 390 
uniquely identifiable nucleotide sequences inserted in non-coding regions of bacterial 391 
chromosomal DNA to generate a pool of iso-phenotypic, genetically distinguishable bacteria. 392 
This bacterial pool is then inoculated into experimental models. Animals are sacrificed at 393 
timepoints of interest, organs harvested, and bacterial composition determined by quantitative 394 
polymerase chain reaction (qPCR) or sequencing. Infection with signature-tagged strains 395 
allows one to follow the course of infection in the infected animal. Because the bacteria are 396 
uniquely marked, one can essentially take snapshots of the infection and determine the rates at 397 
which bacteria replicate, migrate and die in tissues at any time during the course of infection.   398 
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With non-phenotypic marker-based techniques, hosts are inoculated with a mixture of 399 
uniquely-tagged bacterial subpopulations, each of which evolves as an independent infection 400 
in vivo. Unlike the few unique phenotypes used as markers in the additive marker-based 401 
methods, the multiplicity of infections per model animal using this new generation of non-402 
phenotypic techniques reduces the number of hosts required to yield a sufficient volume of data 403 
to decipher the unobserved dynamics and allow the quantification of replication, killing and 404 
migration of bacteria in vivo (Coward et al., 2014; Melton-Witt et al., 2011; Grant et al., 2008; 405 
Barnes et al., 2006).  The recent introduction of next-generation sequencing in place of qPCR 406 
for identification and quantification of the uniquely tagged strains has led to even higher-407 
resolution data (Zhang et al., 2017; Abel et al., 2015).  408 
DNA barcoding experiments have served as an archetype of successfully pairing mathematical 409 
with experimental approaches. On many occasions, genetic barcodes have been used in the 410 
absence of mathematical models to provide a qualitative assessment of the within-host 411 
dynamics of bacterial infections (Zhang et al., 2017; Abel et al., 2015; Lim et al., 2014; Walters 412 
et al., 2012). In a standard infection, observation of a change from a dissimilar to a highly 413 
similar composition of tagged populations between two tissue samples would indicate bacterial 414 
migration between them, while the sudden loss of tagged strain diversity would suggest a rapid 415 
bottleneck. For instance, Walters et al. (2012) used isogenic tagging experiments to show a 416 
bottleneck in the uropathogenic Escherichia coli infection between the kidney and the 417 
bloodstream.  418 
However, mathematical models allow for a quantitative assessment of the dynamics of the 419 
bacterial infection, as well as model selection. For instance, the observed composition of 420 
isogenically-tagged populations of bacteria is the result of the convolved effects of replication, 421 
killing, and migration. By using a within-host model which explicitly represents the processes 422 
of replication, killing, and migration, it is possible to precisely estimate these rates by 423 
comparing model outputs to experimental data. The precision of parameter estimation is 424 
usually reported in the form of confidence intervals (Coward et al., 2017; Kaiser et al., 2014; 425 
Kaiser et al., 2013; Dybowski et al., 2015; Grant et al., 2008). Increasing the precision of 426 
inference has been achieved by using a larger pool of Isogenically-tagged strains (STAMP 427 
references) or using inocula with only a small proportion of tagged strains (Kaiser et al., 2014; 428 
Kaiser et al., 2013) Apart from quantifying the contribution of different processes in the overall 429 
bacterial numbers, it is also possible to assess the plausibility of different biological hypotheses 430 
by selecting the model with the best fit to the data (Figure 3).  431 
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Two published studies demonstrate the biological insights offered by complementing the 432 
qualitative data interpretation with the quantitative model output. First, Grant et al. (2008) 433 
demonstrated using the estimates provided by modelling that in the early stages of infection, 434 
replication and killing lead to unique subpopulations of bacteria in different infection foci. 435 
Estimation of replication and killing rates would not have been possible without using a 436 
mathematical model.  437 
Secondly, Coward et al. (2014) introduced elements of mathematical modelling at various 438 
points along the experimental timeline. In the early stages of experimental design, simulation-439 
based experiments were used to determine the inoculum dose that would yield the most 440 
informative experimental output. Then, mathematical modelling was used to correct the raw 441 
experimental data by accounting for the noise introduced due to partial sampling and the 442 
samples undergoing qPCR. Finally, mathematical modelling was used to maximise the 443 
biological insight by enabling the comparison between the mechanisms of action of the live 444 
and killed vaccine. Without models, net growth could be estimated from CFU counts, but 445 
distinguishing between the bactericidal and bacteriostatic effects of the two vaccines would 446 
have been unfeasible. 447 
Even though mathematical modelling applied on experimental studies using non-phenotypic 448 
markers has been widespread in the field of within-host bacterial dynamics, there are 449 
limitations. Non-phenotypic marker-based techniques can only capture the dynamics at the 450 
bacterial population level, treat the bacterial population in question as having homogenous 451 
dynamics and do not provide data in the form of a time series, as different mice are sacrificed 452 
at each time point of interest. As a result, the inferences made regarding the rates at which the 453 
in-host dynamics evolve can only represent the average of the heterogeneous dynamics at play 454 
(Claudi et al., 2014). Meanwhile, the assumptions that inter-mice immunological responses are 455 
identical and that inter-strain differences remain negligible over time have not been tested. 456 
Finally, even in the presence of sufficient data to infer the parameters governing the in vivo 457 
dynamical processes, mathematical models have hitherto been limited to constant-rate 458 
























Figure 3: Model selection in a virtual study using tagged strains 481 
 482 
Mice are infected with an equiproportionate mix of 10 wild-type isogenic strains (WITS) at t0. At t1, 483 
mice are sacrificed and bacterial copies per WITS are enumerated in their blood, liver and spleen. 484 
Colour-filled circles represent present strains, while unfilled circles represent absent strains.  The joint 485 
distribution of bacteria per WITS in the 3 tissues uniquely describes the state of the system at 486 
t1.  Estimated bacterial distributions A and B are obtained at t1 for competing models A and B. Each 487 
estimated distribution is compared to the observed distribution and their difference summarised by a 488 
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3.2. Fluorescence Dilution-Based Techniques 494 
 495 
Fluorescence dilution techniques take the observation of the within-host bacterial dynamics 496 
from the population- to the single-cell level (Myhrvold et al., 2015; Claudi et al., 2014; Helaine 497 
et al., 2014, Helaine et al., 2010). Fluorescence reporter plasmids, in which dilution of a 498 
preformed pool of a fluorophore (fluorescence dilution) acts as a measure of bacterial 499 
replication, are introduced into a bacterial population. Flow cytometry is used to determine the 500 
intensity of the signal and thus the number of replication events that bacteria have undergone. 501 
 502 
By virtue of its single-cell resolution, fluorescence dilution techniques are particularly useful 503 
to study bacterial heterogeneity. To this day, mathematical modelling has typically not been 504 
used for fluorescence-dilution type experiments. Analyses have focused on qualitatively 505 
characterising the heterogeneity in a signal across a bacterial population, e.g. with regards to 506 
its spectrum of replication rates. 507 
 508 
However, mathematical modelling is needed to precisely quantify the extent of heterogeneity 509 
in the biological attribute of interest and to test hypotheses that may underlie this heterogeneity. 510 
In theory, because fluorescence halves at each division in fluorescence dilution experiments, 511 
discrete peaks should be observed on the histogram of fluorescence corresponding to bacteria 512 
at specific numbers of generations. Nonetheless, the histogram of fluorescence intensity is 513 
continuous. It is likely that this incongruence reflects some heterogeneity in the experimental 514 
process. Mathematical modelling can help distinguish the heterogeneity from the experimental 515 
process from the heterogeneity in the biological process. In particular, stochastic models are 516 







































Observed distribution of fluorescence 
intensity in bacterial population 
OR 
The distribution could also represent a few bacterial 
subpopulations with distinct division rates and 
variations due to asynchronous division events, 
errors in measurements of the fluorescence intensity 
and variations in fluorophore maturation. 
The continuous distribution could 
represent multiple bacterial 
subpopulations with a range of 
division rates. 
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In slow-dividing bacteria, the 
fluorophore has time to convert 
from green to orange before 
dilution with replication 
In rapidly-dividing bacteria, the 
green:orange fluorophore ratio is 
high, as the fast replication does 
not allow time for green to orange 
conversion 
Bacteria with different replication rates have different green: orange fluorescence, which can be visualised at 
the population-level as follows: 
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Figure 4: Coupling mathematical modelling with TIMER technique to distinguish between true 554 
variation in bacterial division rates and variation due to observational process (adapted from 555 
Claudi et al., 2014) 556 
The observed distribution of fluorescence intensity in the bacterial population appears continuous. 557 
Using stochastic models it is possible to quantify the variation expected from different identified sources 558 
of noise, and compare it to the variation in the experimental data. If the aggregate variation from all 559 
sources of noise can account for the variation in the data, it is not necessary to implicate models of 560 




3.3. Peak-To-Trough Ratio 565 
 566 
One of the most recently developed technique pertinent to facilitating the observation of in 567 
vivo bacterial dynamics makes use of the differential genetic signatures left by replication 568 
cycles (Korem et al., 2015).  During DNA replication, regions that have already been passed 569 
by the replication fork will have two copies while the yet unreplicated regions will have a single 570 
copy. The ratio between DNA copy number near the replication origin and that near the 571 
terminus, termed peak-to-trough ratio (PTR) should reflect the growth rate of the bacterial 572 
population.  573 
 574 
In 2018, Gao and Li developed an algorithm allowing the quantitative inference of bacterial 575 
growth rates from PTR data, which include DNA segments from various bacterial genomes in 576 
a faecal sample. This multi-genomic sample comprises sets of overlapping DNA fragments 577 
(contigs), which upon alignment can provide information about the pathogen’s identity and 578 
replication history. The first step of the algorithm allows for correction of sequencing bias (GC 579 
content bias is often reported in next-generation sequencing). This is achieved by using a linear 580 
mixed effect model, which corrects the average contig coverage according to the average GC 581 
content difference in the set. Quality control and exclusion of contigs is followed by a principal 582 
component analysis of contig coverages in multiple samples leading to more accurate inference 583 
of the distance between the contig and the replication origin compared to single samples. 584 
Quantification of parameter estimate accuracy when using experimental data of variable quality 585 
(e.g. different number of contig sizes, degree of contamination, contig number) is possible. 586 
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This feature could be relevant to experimental design, as it could inform experimental 587 
biologists of the trade-off between data quality and level of inference accuracy.   588 
 589 
 590 
  591 
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4. Biological Themes Explored with the Use of Models  592 
 593 
Sections 2 and 3 have introduced necessary conceptual tools to appreciate the insight that 594 
mathematical models can offer when used in conjunction with experimental data. We hope that 595 
we have also provided a rough guide of how different formats of data can be explored 596 
mathematically. The purpose of the present section is to present biological themes which 597 
customarily come up in the study of within-host dynamics of infectious disease and how they 598 
have been addressed through the use of mathematical models. As modelling examples remain 599 
limited in the area of bacterial dynamics, we include conceptually similar studies in other 600 
pathogenic classes including viruses and parasites. These case studies are by no means an 601 
exhaustive representation of the entirety of the literature body but have been selected to serve 602 
as illustrations of the concepts. 603 
 604 
4.1. Quantification of the relative contribution of different immune system components 605 
to the progression of infection 606 
 607 
Within-host models of parasitic, viral and bacterial infection often seek to determine the 608 
relative contributions of different components of the immune system in regulating the 609 
dynamics of infection. In the current treatment paradigm, the role of the host’s immune 610 
response is often neglected, and therapeutic agents are administered for fixed periods of time 611 
usually in the form of monotherapy and regardless of the infectious load. It is now becoming 612 
increasingly recognised that a first step towards optimisation of existing therapies is the 613 
induction of synergistic effects between the host immunity and the standalone effect of the 614 
therapy (Gjini and Brito, 2016).  To thoroughly understand this interaction, mechanistic 615 
mathematical models can be used in two main ways. Firstly, one can use a series of nested 616 
models prospectively, starting from simpler models and adding features of the immune 617 
response while quantifying the impact of each new addition in the process. Secondly, by 618 
enabling the segregation between unobserved processes of replication and killing, 619 
mathematical models begin to shed light on the black-box of host-pathogen interactions and 620 
inform further biological experiments. For example, if rapid killing is identified as the main 621 
driver of an observed decline in bacterial numbers, it is reasonable to first look in the direction 622 




One such approach was taken by Grant et al. in 2008 where following the identification of 625 
early bactericidal activity in a Salmonella mouse model, infection progression in wild type 626 
mice was compared to that in NADPH oxidase deficient mice to unravel an important role of 627 
that immunological component in inducing the inferred bactericidal effect. In other pathogen 628 
classes, mathematical models addressing similar questions were successfully used much earlier.  629 
 630 
With regards to host immune system-bacterial interactions, mathematical modelling of the 631 
Mycoplasma species has been ongoing. The Kirschner group have developed a series of 632 
increasingly complex mathematical models to describe the role of different cell types and 633 
chemokines of the immune system in the progression of early tuberculosis (TB) infection. Their 634 
compartmental model based on ordinary differential equations including the lung and the 635 
draining lymph node (DNL) has been used to study the dynamics of early infection, particularly 636 
the role of dendritic cells in T-cell priming (Marino & Kirschner, 2004) and, later, the roles of 637 
dendritic cell trafficking to and from the DNL (Marino et al., 2004), cytotoxic T-cell-mediated 638 
Mycobacteria killing (Sud et al., 2006), TNF-α and anti-inflammatory IL-10 (Cilfone et al., 639 
2014)  in host defence. Their contributions identified the macrophage infection rate and T-cell-640 
mediated immunity as the two key elements in determining the trajectory of an infection into 641 
one of a) primary TB, b) primary TB with clearance, c) latency, d) reactivation (Marino & 642 
Kirschner, 2004). 643 
 644 
4.2. Comparison of the effect of different strains on infection dynamics 645 
 646 
Fitting within-host models to samples of different strains of the infectious pathogen can also 647 
facilitate our understanding of how the within-host dynamics of infection vary across different 648 
strains of the same species. Different strains of pathogens are responsible for differences in 649 
seasonal and local outbreaks of contagious and deadly infections such as influenza (Du et al., 650 
2017), cholera (Weill, Domman et al., 2018), community-acquired pneumonia (Zhang et al., 651 
2019) and others. These pathogens, albeit very closely related, can show extreme differences 652 
in transmission rates (e.g. in Mycobacterium tuberculosis in Verma et al., 2019), response to 653 
therapeutic agents (e.g. in Vibrio cholerae in Weill, Domman et al., 2018) and virulence (e.g. 654 
in swine fever virus in Portugal et al., 2015). In this context, mathematical models allow for 655 
sensitivity analyses to identify which parameter(s) have the greatest impact on a given outcome; 656 




For instance, Hur et al. (2013) fit models of influenza infection to experimental data on 659 
seasonal and pandemic strains of flu. They found that the only parameter that varied between 660 
the pandemic and seasonal strains was the viral replication rate, indicating that intracellular 661 
viral replication may affect pathogenicity.  662 
 663 
4.3. Comparison of the effects of different therapeutic interventions on infection 664 
dynamics 665 
 666 
Within-host models of infection (both theoretical data-driven) can also reveal important 667 
insights into the effect of different drugs at the level of the host-pathogen interaction, and 668 
identify effective treatment strategies (e.g., decide whether it is more efficient to prevent 669 
replication or increase killing).  For example, Rong and Perelson (2014) evaluated the effect of 670 
different Hepatitis C (HCV) treatment strategies. Protease inhibitors are being increasingly 671 
used in combination with pegylated interferon and ribavirin to treat HCV-1 infection, but there 672 
remain concerns of relapse after treatment. They developed a deterministic mathematical 673 
model to examine viral load dynamics before and after treatment with a protease inhibitor. 674 
Banerjee, Keval and Gakkhar (2013) considered the effect of ribavirin being used in 675 
combination with interferon therapy for HCV infection. Although the study was theoretical in 676 
nature, it found that - provided a certain threshold of drug efficacy - a triphasic response of 677 
viral load could be observed, leading to eradication of the virus.  678 
 679 
4.4. Comparison of the effects of different inoculum size on infection dynamics 680 
 681 
Infections can take off with inocula of variable sizes. However, the inoculum size affects the 682 
population composition of the infectious agents and how they respond to therapy. Formulating 683 
a deterministic mechanistic model, Meredith et al. (2015) reported that inoculum size 684 
determines the efficacy of β-lactam antibiotics when administered to bacterial populations of 685 
which at least some members harbour extended β-lactamase activity. If β-lactam antibiotics 686 
were administered in high-density populations, then some members would survive and re-687 
establish the infection. They reported that the population was sensitive when its initial density 688 
was sufficiently low or examined in a short time window. Given these properties, they reasoned 689 
that optimal antibiotic dosing may remain effective in bacterial populations even when they 690 




4.5. Studying the dynamics of infection across different scales 693 
 694 
Mathematical models can be employed to study host-pathogen interactions at multiple levels, 695 
from cellular to whole-organism and even population level. A solid knowledge of the versatility 696 
of mathematical techniques allows the use of the same tools to study questions on different 697 
scales. With judicious use, mathematical models can also combine insight acquired at different 698 
levels e.g. the single cell and organ levels and use this to gain novel insights about disease 699 
progression (Gog et al., 2015). For example, a stochastic mathematical model generated by the 700 
Perelson lab showed that early HIV dynamics differ depending on whether infected target cells 701 
produce virions continuously or do so in a single burst (Pearson, Krapivsky & Perelson, 2011). 702 
This study shows how events at the single-cell level can have a profound impact on infection 703 
dynamics at the whole-organism level ultimately affecting clinically important quantities used 704 
for diagnosis and as guides for therapeutic intervention.  705 
 706 
Furthermore, it is possible to use the predictions from modelling the host-pathogen interactions 707 
to inform models at higher scales. In 2009, Heffernan and Keeling took advantage of well-708 
founded predictions about immunity in a measles-infected host  (Heffernan & Keeling, 2008) 709 
to predict the effect of vaccination at the population level.  710 
 711 
  712 
 713 
4.6. Investigating the evolutionary dynamics of infectious disease within the host  714 
 715 
Finally, mathematical models have been used to characterise and quantify the evolutionary 716 
dynamics of infectious agents within a host. For instance, Chisholm and Tanaka (2016) 717 
developed a mechanistic mathematical model to examine the evolution of M. tuberculosis 718 
within its host. M. tuberculosis is observed to enter a latent, dormant state, but, at first glance, 719 
a state of dormancy is not advantageous for the pathogen as it does not permit replication. 720 
However, the study demonstrated that latency can be an evolutionarily desirable state.  721 
 722 
Furthermore, Fabre et al. (2012) formulated a deterministic mechanistic model of competing 723 
viral populations within host plants. They parameterised it according to the carrying capacity 724 
of the plant, the intrinsic rate of increase of each variant and the competition strength each 725 
genotype exerts on the others. They determined the forms of selection processes occurring 726 
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between competing viruses within a host plant, and the intensity and temporal variation of 727 
genetic drift experienced by viruses during host plant colonization. Parameters were 728 
statistically inferred by model fitting to high-throughput sequence data of the viral counts 729 
obtained from the plants over time, and model selection was performed (after testing several 730 




5. Conclusion 735 
 736 
This review attempted to bridge the gap between our increasing observational capacity in the 737 
lab on one hand, and the mathematical modelling approaches whose computational efficiency 738 
is improving on the other. Experimental techniques aiming to observe bacterial replication, 739 
killing and migration are capable of higher and higher resolution. They yield rich experimental 740 
outputs which per se suffice to gain meaningful qualitative insights on the dynamics of 741 
infection. Nevertheless, sole qualitative assessment of the experimental output constitutes a 742 
significant underuse of resources. When in conjunction with bespoke mathematical models, the 743 
same raw data can be used to segregate between unobserved processes when solely their 744 
convolved effects are observed, to quantify the rates at which these processes occur, and to test 745 
competing hypotheses regarding the underlying biological mechanisms. Ultimately, a 746 
quantitative measure of the likelihood of a biological hypothesis can inform resource allocation 747 
in further experimental studies. 748 
 749 
Furthermore, the role of mathematical modelling in optimising experimental conditions should 750 
not be overlooked, as an experimental protocol design that ignores the modelling aspect is set 751 
up to obtain data that would most likely be suboptimal for modelling (Succurro, Moejes and 752 
Ebenhöh, 2017). As a result, it is crucial that modelers and experimentalists come together at 753 
the conceptual stages of a project to jointly plan experiments, measurement frequency and 754 
timepoints, and data management.  755 
 756 
Due to limited cross-disciplinary training, this dialogue has not been extensive so far. 757 
Nevertheless, attempts to pair certain forms of experimental output to certain mathematical 758 
modelling techniques have begun to emerge recently, as shown conceptually in section 2. This 759 
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creates a standardised platform that makes modelling more accessible to those with less 760 
expertise and highlights the recognition of the added value of bringing mathematical models 761 
and experimental data together.  762 
 763 
In recent years decisive steps have been taken in the direction of establishing customisable 764 
modelling platforms corresponding to specific data formats. First, Price et al. (2017) developed 765 
a freely-available package in the R programming language facilitating the implementation of 766 
mathematical models on DNA barcoding data. Secondly, Gao and Li (2018) developed an 767 
algorithm allowing the quantification of bacterial replication rates from PTR data. In 768 
recognition of the added value that mathematical models can provide when combined with 769 
experimental data, these efforts highlight the recently increasing interest in expanding the 770 
dialogue between experimentalists and modellers using tools that can be understood and used 771 
by both parties. We hope that by presenting a pairwise overview between experimental 772 
techniques and mathematical modelling approaches, we have not only illustrated the versatility 773 
of models in addressing a wide range of biological questions, but also provided the impetus for 774 
microbiologists to reconsider the role of modelling at all stages of the experimental procedure. 775 
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